Press Release
The Pisanchyn Law Firm Secures Major Settlements in Two Complex Workers' Compensation Cases
The Pisanchyn Law Firm secured over $2.2 million in combined settlements for injured Pennsylvania workers, including a $786K product liability case and a $1M+ multi-party truck injury case. Read More
Press Release
ZUMA Press Inc and Scott Mc Kiernan Presents Launches: THE PICTURES of the WEEK
ZUMA Press Inc celebrates its' 30th Birthday with another visual spectacular publishing product: www.thePicturesOftheWeek.com Must see photography Every Friday, as ZUMA brings you The Best Images Of The Last Seven Days, The Week in Review. Read More
Press Release
Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress
Crofelemer, a novel plant-based anti-secretory prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency (EMA) for both short bowel syndrome (SBS) and microvillus inclusion disease (MVID) and is being evaluated to serve as a potential therapeutic option to manage intestinal failure in these patients There are currently no approved drug treatments for MVID, an ultrarare pediatric disease characterized by severe diarrhea and malabsorption that requires intensive parenteral support for nutritional and fluid management Proof-of-concept data in MVID from this study would provide support for crofelemer's potential inclusion in the EMA's PRIME program for novel medicines targeting unmet medical needs and the FDA's Breakthrough Therapies program Read More
Press Release
Cubic to Demonstrate Command, Control, Communications, Computers, Cyber, Intelligence, Surveillance and Reconnaissance (C5ISR) Solutions for Marine Air-Ground Task Force (MAGTF) Integration Across the Joint Force at Modern Day Marine 2025
Accelerating decision-making at every echelon Read More
Press Release
Healthy Extracts to Report Record First Quarter 2025 with Net Revenue Up More than 34%; Revises Full Year Outlook
Net Revenue Expected to Grow 34%+ in 2025 to $4.2 Million, up From Previous Guidance of $4.0 Million Product Expansion and Growth in Subscription-Based Recurring Revenue Continues to Drive Positive Cash Flow Read More
Press Release
